Margret Schottelius

Walther Meißner Str. 3
Garching Bei Munchen, BY 85748, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

La-[18/19F]fluoride complexes: a novel addition to the radiofluorination family.

La-[18/19F]fluoride complexes: a novel addition to the radiofluorination family.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: March 30, 2026

CXCR4-Targeted Molecular Imaging in Hematology and Oncology.

CXCR4-Targeted Molecular Imaging in Hematology and Oncology.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 22, 2026

Challenges in tracer development for tumor microenvironment (TME) imaging.

Challenges in tracer development for tumor microenvironment (TME) imaging.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 23, 2026

Is CXCR4 Theranostics in Oncologic, Cardiovascular, and Inflammatory Diseases Really Happening?

Is CXCR4 Theranostics in Oncologic, Cardiovascular, and Inflammatory Diseases Really Happening?

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 28, 2025

[99mTc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T family.

[99mTc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T family.

Journal: European journal of nuclear medicine and molecular imaging

Published: September 16, 2025

Utility of [99mTc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a feasibility study.

Utility of [99mTc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a feasibility study.

Journal: Cancer immunology, immunotherapy : CII

Published: May 22, 2025

Novel radiohybrid PET-Tracers for SST2-targeted imaging of neuroendocrine tumors.

Novel radiohybrid PET-Tracers for SST2-targeted imaging of neuroendocrine tumors.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 14, 2025

Identifying and navigating bottlenecks in the translation of novel radiopharmaceuticals: a perspective.

Identifying and navigating bottlenecks in the translation of novel radiopharmaceuticals: a perspective.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 20, 2024

[99mTc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction.

[99mTc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction.

Journal: Circulation. Cardiovascular imaging

Published: November 13, 2024

Correction to: Preclinical SPECT and PET: Joint EANM and ESMI procedure guideline for implementing an efficient quality control programme.

Correction to: Preclinical SPECT and PET: Joint EANM and ESMI procedure guideline for implementing an efficient quality control programme.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 29, 2024

C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study.

C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 02, 2024

Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activation.

Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activation.

Journal: EJNMMI research

Published: May 21, 2024

Showing 1-12 of 85

Last Updated: 09/26/2026